Renal Cancer - Results from #6200

Improved health-related quality of life of patients with metastatic renal cell carcinoma treated with a 2 weeks on and 1 week off schedule of sunitinib - Abstract June 1, 2015

Five-year analysis of a multi-institutional prospective clinical trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM registry - Abstract June 1, 2015

Good tolerability, long-term survival and easy management of side effects in a patient with metastatic renal cell carcinoma treated with pazopanib - Abstract June 1, 2015

Acute scrotal pain and priapism: An early sign of progression in metastatic renal cell carcinoma? - Abstract May 29, 2015

Kidney cancer, version 3.2015 - Abstract May 29, 2015

Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: Impact of TKIs' antiangiogenic activity - Abstract May 29, 2015

Prognostic impact of renin-angiotensin system blockade on renal cell carcinoma after surgery - Abstract May 29, 2015

Percutaneous radiofrequency ablation of renal tumors: Update 2015 - Abstract May 29, 2015

Targeted therapy in renal carcinoma: A case of long-term effect with complete control of toxicity - Abstract May 29, 2015

Posttraumatic stress and depressive symptoms in renal cell carcinoma: Association with quality of life and utility of single-item distress screening - Abstract May 27, 2015

Rationale and protocol of SOAP: A phase II study to evaluate the efficacy of sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma - Abstract May 27, 2015

Survival outcomes and tumor IMP3 expression in patients with sarcomatoid metastatic renal cell carcinoma - Abstract May 27, 2015

Therapeutic effects and associated adverse events of first-line treatments of advanced renal cell carcinoma (RCC): A meta-analysis - Abstract May 26, 2015

Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project - Abstract May 26, 2015

The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: A population-based study - Abstract May 26, 2015

Significance of pathologic T3a upstaging in clinical T1 renal masses undergoing nephrectomy - Abstract May 26, 2015

Pathologic stage T3a significantly increases disease recurrence across all tumor sizes in renal cell carcinoma - Abstract May 26, 2015

Role of MRI in indeterminate renal mass: Diagnostic accuracy and impact on clinical decision making - Abstract May 25, 2015

Targeted therapies for renal cell carcinoma in Chinese patients: Focus on everolimus - Abstract May 22, 2015

Immunological response and overall survival in a subset of advanced renal cell carcinoma patients from a randomized phase 2/3 study of naptumomab estafenatox plus IFN-α versus IFN-α - Abstract May 22, 2015

Page 311 of 456